Published in J Gastroenterol Hepatol on April 01, 2011
High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma. J Gastroenterol (2013) 1.00
Diagnostic value of AFP-L3 and PIVKA-II in hepatocellular carcinoma according to total-AFP. World J Gastroenterol (2013) 0.94
Biomarkers for hepatocellular carcinoma: diagnostic and therapeutic utility. Hepat Med (2015) 0.84
Novel Lens culinaris agglutinin-reactive fraction of α-fetoprotein: a biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations. Int J Clin Oncol (2011) 0.77
Changes in highly sensitive alpha-fetoprotein for the prediction of the outcome in patients with hepatocellular carcinoma after hepatectomy. Cancer Med (2014) 0.76
History and recent progress in evaluation of the fucosylated alpha-fetoprotein fraction. J Gastroenterol Hepatol (2011) 0.75
Architectural roles of multiple chromatin insulators at the human apolipoprotein gene cluster. EMBO J (2009) 2.56
Strategic compartmentalization of Toll-like receptor 4 in the mouse gut. J Immunol (2003) 2.37
Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment. Dig Endosc (2013) 2.30
Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol (2014) 2.30
FGF3/FGF4 amplification and multiple lung metastases in responders to sorafenib in hepatocellular carcinoma. Hepatology (2013) 1.81
Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol (2006) 1.79
Which landmark results in a more consistent diagnosis of Barrett's esophagus, the gastric folds or the palisade vessels? Gastrointest Endosc (2006) 1.70
Effect of (R)-2-(2-aminothiazol-4-yl)-4'-{2-[(2-hydroxy-2-phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective beta3-adrenoceptor agonist, on bladder function. J Pharmacol Exp Ther (2007) 1.65
Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol (2005) 1.57
Reg protein is overexpressed in gastric cancer cells, where it activates a signal transduction pathway that converges on ERK1/2 to stimulate growth. FEBS Lett (2002) 1.56
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens. J Gastroenterol (2003) 1.54
Inflammatory bowel disease: review from the aspect of genetics. J Gastroenterol (2009) 1.51
Radially asymmetric gastroesophageal acid reflux in the distal esophagus: examinations with novel pH sensor catheter equipped with 8 pH sensors. J Gastroenterol (2012) 1.49
Growth inhibition of esophageal squamous carcinoma cells by peroxisome proliferator-activated receptor-gamma ligands. J Lab Clin Med (2002) 1.46
Usefulness of catheterless radiotelemetry pH monitoring system to examine the relationship between duodenal acidity and upper gastrointestinal symptoms. J Gastroenterol Hepatol (2011) 1.44
Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity. J Urol (2011) 1.43
Is a computerized bowel sound auscultation system useful for the detection of increased bowel motility? Am J Gastroenterol (2002) 1.41
MFG-E8 attenuates intestinal inflammation in murine experimental colitis by modulating osteopontin-dependent alphavbeta3 integrin signaling. J Immunol (2009) 1.38
Essential role of MD-2 in TLR4-dependent signaling during Helicobacter pylori-associated gastritis. J Immunol (2004) 1.33
Design of novel inorganic-organic hybrid materials based on iron-chloranilate mononuclear complexes: characteristics of hydrogen-bond-supported layers toward the intercalation of guests. J Am Chem Soc (2003) 1.29
Difference in localization of esophageal mucosal breaks among grades of esophagitis. J Gastroenterol Hepatol (2006) 1.24
Localization of early-stage dysplastic Barrett's lesions in patients with short-segment Barrett's esophagus. Am J Gastroenterol (2006) 1.21
The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse. PLoS One (2011) 1.20
Consumption of uncooked deer meat as a risk factor for hepatitis E virus infection: an age- and sex-matched case-control study. J Med Virol (2004) 1.20
Muscle oxidative capacity during IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp Physiol (2010) 1.19
The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma. Clin Cancer Res (2005) 1.18
A new water instillation method for colonoscopy without sedation as performed by endoscopists-in-training. Gastrointest Endosc (2002) 1.17
Barrett's esophagus in Japanese patients: its prevalence, form, and elongation. J Gastroenterol (2008) 1.17
The function of the psoas major muscle: passive kinetics and morphological studies using donated cadavers. J Orthop Sci (2002) 1.16
A Japanese case of eosinophilic esophagitis. J Gastroenterol (2006) 1.13
Predictors for squamous re-epithelialization of Barrett's esophagus after endoscopic biopsy. J Gastroenterol Hepatol (2007) 1.12
Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle. Mol Cell Endocrinol (2012) 1.12
Angiolipoma of the colon diagnosed after endoscopic resection. Gastrointest Endosc (2002) 1.11
Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol (2015) 1.08
Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis. Biochem Biophys Res Commun (2004) 1.06
Gut barrier dysfunction in the Apc(Min/+) mouse model of colon cancer cachexia. Biochim Biophys Acta (2011) 1.05
Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin Vaccine Immunol (2006) 1.04
Upper gastrointestinal complications associated with gemcitabine-concurrent proton radiotherapy for inoperable pancreatic cancer. J Gastroenterol (2013) 1.03
The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse. J Cachexia Sarcopenia Muscle (2011) 1.03
Complications of radiofrequency ablation for hepatocellular carcinoma in a multicenter study: An analysis of 16 346 treated nodules in 13 283 patients. Hepatol Res (2012) 1.02
Transgenic overexpression of Reg protein caused gastric cell proliferation and differentiation along parietal cell and chief cell lineages. Oncogene (2004) 1.02
IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse. Skelet Muscle (2012) 1.02
A randomized, placebo-controlled, double-blind clinical trial of rikkunshito for patients with non-erosive reflux disease refractory to proton-pump inhibitor: the G-PRIDE study. J Gastroenterol (2014) 1.01
Double-balloon endoscopy for treatment of small bowel penetration by fish bone. Dig Endosc (2012) 1.00
Gastric ulcer associated with cytomegalovirus in an immunocompetent patient: method for diagnosis. Case Rep Gastroenterol (2012) 0.99
Psychometric validation of the Japanese translation of the Quality of Life in Reflux and Dyspepsia questionnaire in patients with heartburn. J Gastroenterol (2007) 0.98
Clinical characteristics of Japanese patients with eosinophilic esophagitis and eosinophilic gastroenteritis. J Gastroenterol (2012) 0.98
Tolerance to famotidine and ranitidine treatment after 14 days of administration in healthy subjects without Helicobacter pylori infection. J Gastroenterol Hepatol (2003) 0.98
BRAF and K-ras gene mutations in human pancreatic cancers. Cancer Lett (2003) 0.97
Effects of mosapride on esophageal functions and gastroesophageal reflux. J Gastroenterol Hepatol (2010) 0.96
Effects of a new ultrasonic scaler on fibroblast attachment to root surfaces: a scanning electron microscopy analysis. J Periodontal Res (2004) 0.95
Half-solidification of nutrient does not decrease gastro-esophageal reflux events in patients fed via percutaneous endoscopic gastrostomy. Clin Nutr (2009) 0.95
Unsedated transnasal small-caliber esophagogastroduodenoscopy in elderly and bedridden patients. World J Gastroenterol (2009) 0.94
Influence of acid suppressants on gastric emptying: cross-over analysis in healthy volunteers. J Gastroenterol Hepatol (2006) 0.94
In vitro and in vivo tissue selectivity profile of solifenacin succinate (YM905) for urinary bladder over salivary gland in rats. Eur J Pharmacol (2004) 0.94
Inhibitory effects of a selective endothelin-A receptor antagonist YM598 on endothelin-1-induced potentiation of nociception in formalin-induced and prostate cancer-induced pain models in mice. J Cardiovasc Pharmacol (2004) 0.93
Asymmetrical circumferential distribution of esophagogastric junctional lesions: anatomical and physiological considerations. J Gastroenterol (2009) 0.93
Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury. J Appl Physiol (1985) (2009) 0.93
Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival. Cancer (2004) 0.92
Prevalence of and risk factors for Barrett's esophagus with intestinal predominant mucin phenotype. Scand J Gastroenterol (2006) 0.92
A 2008 questionnaire-based survey of gastroesophageal reflux disease and related diseases by physicians in East Asian countries. Digestion (2009) 0.92
A comparative study of microfocus CT and histomorphometry in the evaluation of bone augmentation in rat calvarium. J Oral Sci (2010) 0.91
Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. Am J Physiol Endocrinol Metab (2013) 0.91
Efficacy of prokinetic agents in improving bowel preparation for colonoscopy. Digestion (2008) 0.91
Rare case of Takayasu's arteritis associated with Crohn's disease. Intern Med (2011) 0.91